Skip to main content
Glama

Guidetopharmacology

by io.github.pipeworx-io

Recent Changes

recent_changes
Read-onlyIdempotent

"What's new with X" / "latest on Y" / "what happened to Z this week / month / quarter" / "updates on Acme" / "news on Tesla recently" / "what's happening with Apple" — change feed for a company in the last N days/weeks/months in ONE parallel call. Fans out to SEC EDGAR (filings since since), GDELT→GNews fallback (news mentions in window — GDELT preferred, GNews when rate-limited or 5xx), USPTO (patents granted; PatentsView API sunset May 2025 so this soft-fails until reactivated). since accepts ISO date ("2026-04-01") or relative shorthand ("7d", "30d", "3m", "1y"). Returns structured changes[] grouped by source + total_changes count + pipeworx:// citation URIs. Use entity_profile instead when you want the static profile (filings + fundamentals + LEI + patents) regardless of window.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type. Only "company" supported today.
sinceYesWindow start — ISO date ("2026-04-01") or relative ("7d", "30d", "3m", "1y"). Use "30d" or "1m" for typical monitoring.
valueYesTicker (e.g., "AAPL") or zero-padded CIK (e.g., "0000320193").

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Adds significant context beyond annotations: describes fallback behavior (GDELT→GNews), notes soft-fail for USPTO due to API sunset, explains return structure (changes grouped by source, total_changes, citation URIs), and idempotency hints are consistent.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is moderately long but well-structured, starting with example queries and covering all aspects. Minor redundancy could be trimmed, but every sentence adds value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With full parameter coverage, no output schema, and sufficient annotations, the description covers purpose, behavior, usage, and alternative tools completely, leaving no gaps for an AI agent.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but description adds value by explaining relative shorthand for 'since' (e.g., '30d') and providing examples for 'value' (ticker or CIK), going beyond the schema descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states it returns a change feed for a company (SEC filings, GDELT/GNews, patents) in a time window. It distinguishes itself from sibling tool 'entity_profile' by explicitly stating when to use the latter for static profiles.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit usage examples ('What's new with X'), states supported entity type (company only), and directs to 'entity_profile' for static profiles, giving clear when-to-use and when-not-to-use guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Guidetopharmacology toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Many tools have overlapping purposes, such as multiple ask_pipeworx variants (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded) that differ only subtly, and a large set of prediction market tools (bet_research, polymarket_arbitrage, polymarket_edges, etc.) that can be easily confused. Entity tools like entity_profile, recent_changes, and compare_entities also overlap significantly. An agent would struggle to pick the right tool without careful reading.

Naming Consistency2/5

Tool names mix snake_case (ask_pipeworx, deep_research, forget) and descriptive phrases without a consistent verb_noun pattern. Some start with verbs (compare, generate, scan) while others are nouns or compound phrases (pipeworx_trending, polymarket_fill_risk). This inconsistency makes it hard to predict tool names.

Tool Count2/5

With 35 tools, this MCP server is overly large and covers many diverse domains (data querying, prediction markets, pharmacology, npm scanning, brand visibility, etc.). Typically, a well-scoped server has 5-15 tools; 35 is excessive and suggests a lack of focus, making it unwieldy for an agent to manage.

Completeness2/5

Despite the large number of tools, the server has notable gaps. For example, the pharmacology section only offers search and interaction tools but no create/update/delete. The memory tools are limited to save/recall/forget. Many meta-tools (discover_tools, suggest_questions) exist but add little substance. The server covers many domains superficially rather than providing full lifecycle coverage for any one domain.

Resources